<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Clinical Ophthalmology</journal-id><journal-title-group><journal-title>Clinical Ophthalmology (Auckland, N.Z.)</journal-title></journal-title-group><issn pub-type="ppub">1177-5467</issn><issn pub-type="epub">1177-5483</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23326184</article-id><article-id pub-id-type="pmc">3544352</article-id><article-id pub-id-type="doi">10.2147/OPTH.S39019</article-id><article-id pub-id-type="publisher-id">opth-7-055</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Comparative analysis of corneal morphological changes after transversal and torsional phacoemulsification through 2.2 mm corneal incision</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Assaf</surname><given-names>Ahmed</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roshdy</surname><given-names>Maged Maher</given-names></name><xref ref-type="corresp" rid="c1-opth-7-055"></xref></contrib><aff id="af1-opth-7-055">Ophthalmology Department, Ain Shams University, Cairo, Egypt</aff></contrib-group><author-notes><corresp id="c1-opth-7-055">Correspondence: Maged Maher Roshdy, 211 Elhegaz St, Elhegaz Sq, Heliopolis, Cairo, Egypt, Tel +20 122 281 1230, Fax +20 22 624 7575, Email <email>dr_maged_roshdy@med.asu.edu.eg</email></corresp></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>08</day><month>1</month><year>2013</year></pub-date><volume>7</volume><fpage>55</fpage><lpage>61</lpage><permissions><copyright-statement>© 2013 Assaf and Roshdy, publisher and licensee Dove Medical Press Ltd</copyright-statement><copyright-year>2013</copyright-year><license><license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="2469" xml_f="2476" txt_i="11" txt_f="18">Purpose</offsets></title><p><offsets xml_i="2487" xml_f="2721" txt_i="19" txt_f="253">This paper compares and evaluates the corneal morphological changes occurring after cataract surgery through a 2.2 mm corneal incision. We use two platforms for comparison and evaluation, transversal and torsional phacoemulsification.</offsets></p></sec><sec><title><offsets xml_i="2743" xml_f="2763" txt_i="255" txt_f="275">Patients and methods</offsets></title><p><offsets xml_i="2774" xml_f="3102" txt_i="276" txt_f="604">This study includes 139 consecutive cataractous eyes (nuclear color 2–4, according to the Lens Opacities Classification System III [LOCSIII]) of 82 patients undergoing cataract surgery through a 2.2 mm corneal incision. Two different phacoemulsification platforms were used and assigned randomly: we used the WhiteStar Signature</offsets><sup><offsets xml_i="3107" xml_f="3108" txt_i="604" txt_f="605">®</offsets></sup><offsets xml_i="3114" xml_f="3254" txt_i="605" txt_f="745"> system with the Ellips™ FX transversal continuous ultrasound (US) mode for group I (mean age: 65.33 ± 6.97 years), and we used the Infiniti</offsets><sup><offsets xml_i="3259" xml_f="3260" txt_i="745" txt_f="746">®</offsets></sup><offsets xml_i="3266" xml_f="3287" txt_i="746" txt_f="767"> system with the OZil</offsets><sup><offsets xml_i="3292" xml_f="3293" txt_i="767" txt_f="768">®</offsets></sup><offsets xml_i="3299" xml_f="3529" txt_i="768" txt_f="998"> Intelligent Phaco (IP) torsional US mode for group II (mean age: 64.02 ± 7.55 years). The corneal endothelium and pachymetry were evaluated preoperatively and at 1 month postoperatively. Incision size changes were also evaluated.</offsets></p></sec><sec><title><offsets xml_i="3551" xml_f="3558" txt_i="1000" txt_f="1007">Results</offsets></title><p><offsets xml_i="3569" xml_f="3696" txt_i="1008" txt_f="1135">All surgeries were uneventful. Before intraocular lens implantation, the mean incision size was 2.24 ± 0.06 mm in both groups (</offsets><italic><offsets xml_i="3704" xml_f="3705" txt_i="1135" txt_f="1136">P</offsets></italic><offsets xml_i="3714" xml_f="3823" txt_i="1136" txt_f="1245"> = 0.75). In terms of corneal endothelial cell density, neither preoperative (I vs II: 2304.1 ± 122.5 cell/mm</offsets><sup><offsets xml_i="3828" xml_f="3829" txt_i="1245" txt_f="1246">2</offsets></sup><offsets xml_i="3835" xml_f="3860" txt_i="1246" txt_f="1271"> vs 2315.6 ± 83.1 cell/mm</offsets><sup><offsets xml_i="3865" xml_f="3866" txt_i="1271" txt_f="1272">2</offsets></sup><offsets xml_i="3872" xml_f="3874" txt_i="1272" txt_f="1274">, </offsets><italic><offsets xml_i="3882" xml_f="3883" txt_i="1274" txt_f="1275">P</offsets></italic><offsets xml_i="3892" xml_f="3951" txt_i="1275" txt_f="1334"> = 0.80) nor postoperative (I vs II: 2264.1 ± 124.3 cell/mm</offsets><sup><offsets xml_i="3956" xml_f="3957" txt_i="1334" txt_f="1335">2</offsets></sup><offsets xml_i="3963" xml_f="3988" txt_i="1335" txt_f="1360"> vs 2270.3 ± 89.9 cell/mm</offsets><sup><offsets xml_i="3993" xml_f="3994" txt_i="1360" txt_f="1361">2</offsets></sup><offsets xml_i="4000" xml_f="4002" txt_i="1361" txt_f="1363">, </offsets><italic><offsets xml_i="4010" xml_f="4011" txt_i="1363" txt_f="1364">P</offsets></italic><offsets xml_i="4020" xml_f="4288" txt_i="1364" txt_f="1632"> = 0.98) differences between the groups were statistically significant. The mean endothelial cell density loss was 1.7% ± 1.6% and 2.0% ± 1.4% in groups I and II, respectively. Furthermore, no significant differences between groups I and II were found preoperatively (</offsets><italic><offsets xml_i="4296" xml_f="4297" txt_i="1632" txt_f="1633">P</offsets></italic><offsets xml_i="4306" xml_f="4336" txt_i="1633" txt_f="1663"> = 0.40) and postoperatively (</offsets><italic><offsets xml_i="4344" xml_f="4345" txt_i="1663" txt_f="1664">P</offsets></italic><offsets xml_i="4354" xml_f="4512" txt_i="1664" txt_f="1822"> = 0.68) in central pachymetry. With surgery, the mean increase in central pachymetry was 28.1 ± 23.6 μm and 24.0 ± 24.0 μm in groups I and II, respectively (</offsets><italic><offsets xml_i="4520" xml_f="4521" txt_i="1822" txt_f="1823">P</offsets></italic><offsets xml_i="4530" xml_f="4538" txt_i="1823" txt_f="1831"> = 0.1).</offsets></p></sec><sec><title><offsets xml_i="4560" xml_f="4570" txt_i="1833" txt_f="1843">Conclusion</offsets></title><p><offsets xml_i="4581" xml_f="4612" txt_i="1844" txt_f="1875">Ellips™ FX transversal and OZil</offsets><sup><offsets xml_i="4617" xml_f="4618" txt_i="1875" txt_f="1876">®</offsets></sup><offsets xml_i="4624" xml_f="4765" txt_i="1876" txt_f="2017"> IP torsional phacoemulsification modes are safe for performing cataract surgery, inducing minimal corneal thickness and endothelial changes.</offsets></p></sec></abstract><kwd-group><kwd>cornea</kwd><kwd>endothelium</kwd><kwd>transversal phacoemulsification</kwd><kwd>torsional phacoemulsification</kwd><kwd>Ellips™ FX</kwd><kwd>OZil<sup>®</sup> IP</kwd></kwd-group></article-meta></front><body><sec><title><offsets xml_i="5022" xml_f="5034" txt_i="2026" txt_f="2038">Introduction</offsets></title><p><offsets xml_i="5045" xml_f="5181" txt_i="2039" txt_f="2175">The main objectives of modern phacoemulsification (phaco) technology are the reduction of ultrasound (US) power and improved efficiency.</offsets><xref ref-type="bibr" rid="b1-opth-7-055"><offsets xml_i="5223" xml_f="5224" txt_i="2175" txt_f="2176">1</offsets></xref><offsets xml_i="5231" xml_f="5436" txt_i="2176" txt_f="2381"> Interrupted phaco modes, improved pump systems, chopping techniques, and vacuum-assisted phaco have reduced the amount of energy needed to remove a cataract and, therefore, the potential associated risks.</offsets><xref ref-type="bibr" rid="b1-opth-7-055"><offsets xml_i="5478" xml_f="5479" txt_i="2381" txt_f="2382">1</offsets></xref><offsets xml_i="5486" xml_f="5487" txt_i="2382" txt_f="2383">,</offsets><xref ref-type="bibr" rid="b2-opth-7-055"><offsets xml_i="5529" xml_f="5530" txt_i="2383" txt_f="2384">2</offsets></xref><offsets xml_i="5537" xml_f="5677" txt_i="2384" txt_f="2524"> However, US power required for traditional or longitudinal phaco continues to be a risk factor for endothelial cell loss and tissue damage.</offsets><xref ref-type="bibr" rid="b3-opth-7-055"><offsets xml_i="5719" xml_f="5720" txt_i="2524" txt_f="2525">3</offsets></xref><offsets xml_i="5727" xml_f="5886" txt_i="2525" txt_f="2684"> Through the use of improved phaco technologies, recent studies on cataract surgery have demonstrated a reduction in corneal endothelial cell loss after phaco.</offsets><xref ref-type="bibr" rid="b4-opth-7-055"><offsets xml_i="5928" xml_f="5929" txt_i="2684" txt_f="2685">4</offsets></xref><offsets xml_i="5936" xml_f="5937" txt_i="2685" txt_f="2686">–</offsets><xref ref-type="bibr" rid="b11-opth-7-055"><offsets xml_i="5980" xml_f="5982" txt_i="2686" txt_f="2688">11</offsets></xref></p><p><offsets xml_i="5996" xml_f="6884" txt_i="2689" txt_f="3577">In an attempt to increase US efficiency during phaco cataract surgery, torsional phaco technology was introduced in 2005. In traditional phaco, the longitudinal movement of the phaco tip pushes nuclear fragments away with each forward stroke, although interrupted US has the supposed advantage of allowing retraction of the pushed nuclear fragments back toward the phaco tip. Furthermore, due to the jackhammer effect, the emulsifying power of longitudinal phaco is only effective during the forward movement of the tip. Conversely, the lateral tip movement of torsional phaco shears the lens material while moving in both directions without a repellent force. It also uses a lower frequency (32 MHz) than traditional phaco (40 MHz), allowing for 20% energy conservation. As such, torsional technology represents a significant improvement in the emulsifying efficiency of US during phaco.</offsets><xref ref-type="bibr" rid="b12-opth-7-055"><offsets xml_i="6927" xml_f="6929" txt_i="3577" txt_f="3579">12</offsets></xref><offsets xml_i="6936" xml_f="6937" txt_i="3579" txt_f="3580">,</offsets><xref ref-type="bibr" rid="b13-opth-7-055"><offsets xml_i="6980" xml_f="6982" txt_i="3580" txt_f="3582">13</offsets></xref><offsets xml_i="6989" xml_f="7110" txt_i="3582" txt_f="3703"> Torsional US can also be mixed, intermittently, with a quantum of longitudinal phaco. This is commercially known as OZil</offsets><sup><offsets xml_i="7115" xml_f="7116" txt_i="3703" txt_f="3704">®</offsets></sup><offsets xml_i="7122" xml_f="7397" txt_i="3704" txt_f="3979"> Intelligent Phaco (IP) (Alcon Laboratories, Fort Worth, TX, USA), whereby the quantum is liberated at a threshold vacuum in a duration ranging from 10 to 20 milliseconds. IP aims to maximize torsional US efficacy by keeping the nuclear fragments in the ideal shearing plane.</offsets><xref ref-type="bibr" rid="b14-opth-7-055"><offsets xml_i="7440" xml_f="7442" txt_i="3979" txt_f="3981">14</offsets></xref></p><p><offsets xml_i="7456" xml_f="8161" txt_i="3982" txt_f="4687">In addition to torsional technology, transversal US technology is a new form of phaco. The transversal US model, Ellips™ (Abbott Medical Optics, Santa Ana, CA, USA), was developed to reduce the repulsion that commonly occurs with longitudinal phaco. Ellips™ simultaneously generates lateral and longitudinal motions at a working frequency of 28 kHz; thus, the phaco tip moves in an elliptical motion, promoting an optimization of efficiency by emulsifying lens matter in more than one direction. Moreover, the accompanying longitudinal component adds the jackhammering effect to transversal US efficiency, constantly maintaining the nuclear fragments at the ideal shearing plane in front of the phaco tip.</offsets><xref ref-type="bibr" rid="b15-opth-7-055"><offsets xml_i="8204" xml_f="8206" txt_i="4687" txt_f="4689">15</offsets></xref><offsets xml_i="8213" xml_f="8382" txt_i="4689" txt_f="4858"> The transversal technology can also be used with a straight or curved tip, and the Ellips™ model can work in a continuous or hyperpulse mode with different duty cycles.</offsets><xref ref-type="bibr" rid="b16-opth-7-055"><offsets xml_i="8425" xml_f="8427" txt_i="4858" txt_f="4860">16</offsets></xref><offsets xml_i="8434" xml_f="8764" txt_i="4860" txt_f="5190"> Recently, Ellips™ FX (Abbott Medical Optics), a further hardware and software modification on the previous version, has been developed for a working frequency of 38 kHz (a 45% increase on the previous version) and a stroke length three times larger (longitudinal and lateral stroke length ratio is 1:1) than the previous version.</offsets></p><p><offsets xml_i="8771" xml_f="8903" txt_i="5191" txt_f="5323">Existing studies have experimentally compared torsional and transversal phaco systems in terms of vacuum, surge, and thermal effect.</offsets><xref ref-type="bibr" rid="b15-opth-7-055"><offsets xml_i="8946" xml_f="8948" txt_i="5323" txt_f="5325">15</offsets></xref><offsets xml_i="8955" xml_f="8956" txt_i="5325" txt_f="5326">–</offsets><xref ref-type="bibr" rid="b17-opth-7-055"><offsets xml_i="8999" xml_f="9001" txt_i="5326" txt_f="5328">17</offsets></xref><offsets xml_i="9008" xml_f="9047" txt_i="5328" txt_f="5367"> Furthermore, Christakis and Braga-Mele</offsets><xref ref-type="bibr" rid="b5-opth-7-055"><offsets xml_i="9089" xml_f="9090" txt_i="5367" txt_f="5368">5</offsets></xref><offsets xml_i="9097" xml_f="9259" txt_i="5368" txt_f="5530"> recently compared the clinical outcomes obtained after the same surgeon performed cataract surgery with phaco, using three different systems: WhiteStar Signature</offsets><sup><offsets xml_i="9264" xml_f="9265" txt_i="5530" txt_f="5531">®</offsets></sup><offsets xml_i="9271" xml_f="9306" txt_i="5531" txt_f="5566"> Ellips™ FX (transversal), Infiniti</offsets><sup><offsets xml_i="9311" xml_f="9312" txt_i="5566" txt_f="5567">®</offsets></sup><offsets xml_i="9318" xml_f="9323" txt_i="5567" txt_f="5572"> OZil</offsets><sup><offsets xml_i="9328" xml_f="9329" txt_i="5572" txt_f="5573">®</offsets></sup><offsets xml_i="9335" xml_f="9365" txt_i="5573" txt_f="5603"> IP (torsional), and Stellaris</offsets><sup><offsets xml_i="9370" xml_f="9371" txt_i="5603" txt_f="5604">®</offsets></sup><offsets xml_i="9377" xml_f="10037" txt_i="5604" txt_f="6264"> (Bausch and Lomb, Rochester, NY, USA) (longitudinal). These authors evaluated the phaco needle time, chatter, followability, the anterior chamber stability, the level of corneal edema, and the 1-day postoperative visual acuity. However, to date, no comparisons between torsional and transversal phaco have been reported in terms of corneal endothelial changes. Hence, the aim of this study was to compare and evaluate the corneal morphological changes, including endothelial modifications, as an indicator of safety for cataract surgery through a 2.2 mm corneal incision. In this study, we compared and evaluated the transversal and torsional phaco platforms.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="10088" xml_f="10109" txt_i="6266" txt_f="6287">Materials and methods</offsets></title><sec sec-type="subjects"><title><offsets xml_i="10149" xml_f="10157" txt_i="6288" txt_f="6296">Patients</offsets></title><p><offsets xml_i="10168" xml_f="10497" txt_i="6297" txt_f="6626">This study included 139 consecutive cataractous eyes of 82 patients undergoing cataract surgery through a 2.2 mm corneal incision. The inclusion criteria were patients of 45 years or older and the presence of a senile cataract graded as nuclear color (NC) 2–4, according to the Lens Opacities Classification System III (LOCSIII).</offsets><xref ref-type="bibr" rid="b18-opth-7-055"><offsets xml_i="10540" xml_f="10542" txt_i="6626" txt_f="6628">18</offsets></xref><offsets xml_i="10549" xml_f="10791" txt_i="6628" txt_f="6870"> The exclusion criteria were patients with glaucoma, corneal opacities, cornea guttata, abnormal iris, macular degeneration or retinopathy, previous posterior segment surgery, a corneal endothelial cell density (ECD) of less than 1900 cell/mm</offsets><sup><offsets xml_i="10796" xml_f="10797" txt_i="6870" txt_f="6871">2</offsets></sup><offsets xml_i="10803" xml_f="11057" txt_i="6871" txt_f="7125">, neuro-ophthalmic disease, or a history of ocular inflammation. All volunteers were adequately informed and signed a consent form. The study adhered to the tenets of the Declaration of Helsinki, and the study was approved by the local ethical committee.</offsets></p><p><offsets xml_i="11064" xml_f="11324" txt_i="7126" txt_f="7386">One of the two different phaco platforms was assigned to be used with each eye included in this study. Random assignment was performed by coin toss. Accordingly, two groups were differentiated: group I included eyes undergoing phaco via the WhiteStar Signature</offsets><sup><offsets xml_i="11329" xml_f="11330" txt_i="7386" txt_f="7387">®</offsets></sup><offsets xml_i="11336" xml_f="11499" txt_i="7387" txt_f="7550"> platform using the Ellips™ FX transversal continuous ultrasound mode with the 0.9 mm curved microtip, and group II included eyes undergoing phaco via the Infiniti</offsets><sup><offsets xml_i="11504" xml_f="11505" txt_i="7550" txt_f="7551">®</offsets></sup><offsets xml_i="11511" xml_f="11535" txt_i="7551" txt_f="7575"> platform using the OZil</offsets><sup><offsets xml_i="11540" xml_f="11541" txt_i="7575" txt_f="7576">®</offsets></sup><offsets xml_i="11547" xml_f="11598" txt_i="7576" txt_f="7627"> IP torsional phaco with the 0.9 mm/45° Kelman tip.</offsets></p></sec><sec><title><offsets xml_i="11620" xml_f="11640" txt_i="7629" txt_f="7649">Examination protocol</offsets></title><p><offsets xml_i="11651" xml_f="12516" txt_i="7650" txt_f="8515">Preoperatively, all patients had a full ophthalmological examination, including evaluation of the refractive status, uncorrected and corrected distance visual acuity testing (Snellen optotypes and decimal notation), slit lamp examination, and Goldmann applanation tonometry and fundoscopy. Besides these basic clinical tests, corneal endothelial cell analysis and central corneal thickness (CCT) measurements were performed (EM-3000; Tomey, Erlangen, Germany). Corneal endothelial analysis included the measurement and recording of the ECD, the coefficient of variation (CV), and the hexagonality. Patients were also evaluated during the follow-up at 1 day and 1 month after surgery. At 1 day after surgery, intraocular pressure and the integrity of the anterior segment were evaluated. The corneal endothelium and pachymetry were evaluated one month after surgery.</offsets></p></sec><sec><title><offsets xml_i="12538" xml_f="12545" txt_i="8517" txt_f="8524">Surgery</offsets></title><p><offsets xml_i="12556" xml_f="12855" txt_i="8525" txt_f="8824">All surgeries were performed by the same surgeon (AA), using a standard mini-incision of the sutureless micro-coaxial phaco technique. In all cases, a corneal incision of 2.2 mm was planned, followed by a paracentesis of 1.2 mm. After injection of the cohesive ophthalmic viscoelastic device (Healon</offsets><sup><offsets xml_i="12860" xml_f="12861" txt_i="8824" txt_f="8825">®</offsets></sup><offsets xml_i="12867" xml_f="13487" txt_i="8825" txt_f="9445"> GV; Abbott Medical Optics) in the anterior chamber, a curvilinear rhexis of 5–5.5 mm was performed. After hydrodissection, nucleus disassembly was started using the quick-chop technique, impaling the curved phaco-tip in the central part of the nucleus (1–1.5 mm). This was followed by vertical chopping of the nucleus with the Tobias Neuhann chopper (Geuder GmbH, Heidelberg, Germany). The incision size change was tested using the Tsuneoka micro-coaxial incision gauge (Asico, Westmont, IL, USA) after completion of the cortical cleaning and prior to intraocular lens (IOL) implantation. One-piece acrylic IOLs (Tecnis</offsets><sup><offsets xml_i="13492" xml_f="13493" txt_i="9445" txt_f="9446">®</offsets></sup><offsets xml_i="13499" xml_f="13642" txt_i="9446" txt_f="9589"> 1 ZCB00; Abbott Medical Optics) were implanted in all cases. The wound seal was confirmed at the end of the surgery by a negative Seidel test.</offsets></p><p><offsets xml_i="13649" xml_f="13674" txt_i="9590" txt_f="9615">Settings for the Infiniti</offsets><sup><offsets xml_i="13679" xml_f="13680" txt_i="9615" txt_f="9616">®</offsets></sup><offsets xml_i="13686" xml_f="14074" txt_i="9616" txt_f="10004"> platform (torsional) were as follows: the power was set at 100% linear torsional continuous US amplitude; the IP power delivery option was activated to produce a 10 millisecond longitudinal phaco pulse when 95% vacuum was reached; the flow rate was 28 mL/min, with dynamic rise of +1; the vacuum was set at 350 mmHg; and the bottle height was 108 cm. Settings for the WhiteStar Signature</offsets><sup><offsets xml_i="14079" xml_f="14080" txt_i="10004" txt_f="10005">®</offsets></sup><offsets xml_i="14086" xml_f="14545" txt_i="10005" txt_f="10464"> platform (transversal) were as follows: the power of the Ellips™ FX was set at 100% linear continuous transversal US; the aspiration rate was set at 28 and 26 mL/min before and after occlusion, respectively; vacuum parameters were set at a maximum of 320 mmHg; the chamber stabilization environment (CASE) vacuum was set at 280 mmHg; CASE time was set at 500 milliseconds for NC 2 and at 800–1000 milliseconds for NC 3 and 4; and the bottle height was 67 cm.</offsets></p><p><offsets xml_i="14552" xml_f="14670" txt_i="10465" txt_f="10583">The same postoperative treatment was administered to all patients. This included: using moxifloxacin HCl 0.5% (Vigamox</offsets><sup><offsets xml_i="14675" xml_f="14676" txt_i="10583" txt_f="10584">®</offsets></sup><offsets xml_i="14682" xml_f="14769" txt_i="10584" txt_f="10671">; Alcon Laboratories) eye drops three times per day for two weeks; rimexolone 1% (Vexol</offsets><sup><offsets xml_i="14774" xml_f="14775" txt_i="10671" txt_f="10672">®</offsets></sup><offsets xml_i="14781" xml_f="14925" txt_i="10672" txt_f="10816">; Alcon Laboratories) eye drops three times per day for 1 week, then twice per day for the following 2 weeks; tobramycin-dexamethasone (TobraDex</offsets><sup><offsets xml_i="14930" xml_f="14931" txt_i="10816" txt_f="10817">®</offsets></sup><offsets xml_i="14937" xml_f="15000" txt_i="10817" txt_f="10880">; Alcon Laboratories) eye ointment once at bedtime for 2 weeks.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="15041" xml_f="15061" txt_i="10882" txt_f="10902">Statistical analysis</offsets></title><p><offsets xml_i="15072" xml_f="15338" txt_i="10903" txt_f="11169">SPSS statistics software package (v 19.0) for Windows (IBM Corporation, Armonk, NY, USA) was used for statistical analysis. Normality of all data samples was first evaluated by means of the Kolmogorov-Smirnov test. When parametric analysis was possible, the Student </offsets><italic><offsets xml_i="15346" xml_f="15347" txt_i="11169" txt_f="11170">t</offsets></italic><offsets xml_i="15356" xml_f="15472" txt_i="11170" txt_f="11286">-test for paired data was used for comparisons between preoperative and postoperative examinations, and the Student </offsets><italic><offsets xml_i="15480" xml_f="15481" txt_i="11286" txt_f="11287">t</offsets></italic><offsets xml_i="15490" xml_f="15851" txt_i="11287" txt_f="11648">-test for unpaired data was used for the comparison between groups. When parametric analysis was not possible, the Wilcoxon rank-sum test was applied to assess the significance of differences between preoperative and postoperative data, and the Mann–Whitney test was applied for the comparison between groups, in all cases using the same level of significance (</offsets><italic><offsets xml_i="15859" xml_f="15860" txt_i="11648" txt_f="11649">P</offsets></italic><offsets xml_i="15869" xml_f="16066" txt_i="11649" txt_f="11843"> &lt; 0.05). Before the start of the study and according to our previous experience, we estimated that a sample size of 64 eyes per group would be required to detect a mean difference of 10 cell/mm</offsets><sup><offsets xml_i="16071" xml_f="16072" txt_i="11843" txt_f="11844">2</offsets></sup><offsets xml_i="16078" xml_f="16200" txt_i="11844" txt_f="11966"> between both groups, with a standard deviation of 20. Power of the test was set to 0.8 with a significance level of 0.05.</offsets></p><p><offsets xml_i="16207" xml_f="16363" txt_i="11967" txt_f="12123">We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research.</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="16410" xml_f="16417" txt_i="12126" txt_f="12133">Results</offsets></title><p><offsets xml_i="16428" xml_f="17007" txt_i="12134" txt_f="12713">The total number of eyes included in this study was 150 of 88 patients (group I, 85 eyes; group II, 65 eyes). Six patients (11 eyes: six in group I and five in group II) did not complete the postoperative follow-up examinations and were excluded from the study. Therefore, the data used for the statistical analysis included 139 eyes of 82 patients: 79 eyes in group I and 60 eyes in group II. The mean age ± SD was 65.3 ± 7.0 and 64.0 ± 7.6 years in groups I and II, respectively. No statistically significant differences in age were detected between groups (Mann–Whitney test: </offsets><italic><offsets xml_i="17015" xml_f="17016" txt_i="12713" txt_f="12714">P</offsets></italic><offsets xml_i="17025" xml_f="17378" txt_i="12714" txt_f="13067"> = 0.29). According to the LOCSIII, in group I, 29 eyes presented an NC 2 cataract, 41 eyes presented an NC 3 cataract, and nine eyes presented an NC 4 cataract. In group II, a similar distribution of cataract types, according to the LOCSIII, was found: 23 eyes with an NC 2 cataract, 30 eyes with an NC 3 cataract, and seven eyes with an NC 4 cataract.</offsets></p><sec><title><offsets xml_i="17394" xml_f="17440" txt_i="13068" txt_f="13114">Intraoperative and early postoperative changes</offsets></title><p><offsets xml_i="17451" xml_f="17816" txt_i="13115" txt_f="13480">All surgeries were uneventful. Intraoperatively, we observed improved followability with less chattering of free nuclear fragments in both systems. No incisional corneal burns were observed. Before IOL implantation, the mean size of the main incision was 2.24 ± 0.06 mm in both groups, with no statistically significant differences between them (Mann–Whitney test: </offsets><italic><offsets xml_i="17824" xml_f="17825" txt_i="13480" txt_f="13481">P</offsets></italic><offsets xml_i="17834" xml_f="18027" txt_i="13481" txt_f="13674"> = 0.75). On the first postoperative day, the slit lamp examination showed mild stromal corneal folds in both groups with complete resolution at an average of 7 days, ranging from 4 to 10 days.</offsets></p></sec><sec><title><offsets xml_i="18049" xml_f="18076" txt_i="13676" txt_f="13703">Corneal endothelial changes</offsets></title><p><xref ref-type="table" rid="t1-opth-7-055"><offsets xml_i="18130" xml_f="18137" txt_i="13704" txt_f="13711">Table 1</offsets></xref><offsets xml_i="18144" xml_f="18373" txt_i="13711" txt_f="13940"> summarizes the corneal endothelial changes for groups I and II, occurring 1 month after surgery. As shown, we found significant changes in the three parameters analyzed (ECD, CV, and hexagonality) in both groups (Wilcoxon test: </offsets><italic><offsets xml_i="18381" xml_f="18382" txt_i="13940" txt_f="13941">P</offsets></italic><offsets xml_i="18391" xml_f="18526" txt_i="13941" txt_f="14076"> ≤ 0.02) 1 month after surgery, except for the hexagonality in group II. The mean postoperative decrease in ECD was 40.0 ± 37.5 cell/mm</offsets><sup><offsets xml_i="18531" xml_f="18532" txt_i="14076" txt_f="14077">2</offsets></sup><offsets xml_i="18538" xml_f="18562" txt_i="14077" txt_f="14101"> and 45.3 ± 31.7 cell/mm</offsets><sup><offsets xml_i="18567" xml_f="18568" txt_i="14101" txt_f="14102">2</offsets></sup><offsets xml_i="18574" xml_f="18722" txt_i="14102" txt_f="14250"> in groups I and II, respectively. No statistically significant differences in ECD were found between the groups preoperatively (Mann–Whitney test: </offsets><italic><offsets xml_i="18730" xml_f="18731" txt_i="14250" txt_f="14251">P</offsets></italic><offsets xml_i="18740" xml_f="18789" txt_i="14251" txt_f="14300"> = 0.80) and postoperatively (Mann–Whitney test: </offsets><italic><offsets xml_i="18797" xml_f="18798" txt_i="14300" txt_f="14301">P</offsets></italic><offsets xml_i="18807" xml_f="18853" txt_i="14301" txt_f="14347"> = 0.98). In relation to preoperative values (</offsets><xref ref-type="fig" rid="f1-opth-7-055"><offsets xml_i="18894" xml_f="18902" txt_i="14347" txt_f="14355">Figure 1</offsets></xref><offsets xml_i="18909" xml_f="19038" txt_i="14355" txt_f="14484">), group I showed a mean endothelial cell loss of 1.7% ± 1.6%, whereas group II showed a loss of 2.0% ± 1.4% (Mann–Whitney test: </offsets><italic><offsets xml_i="19046" xml_f="19047" txt_i="14484" txt_f="14485">P</offsets></italic><offsets xml_i="19056" xml_f="19182" txt_i="14485" txt_f="14611"> = 0.29). Regarding CV, no statistically significant differences were found between groups preoperatively (Mann–Whitney test: </offsets><italic><offsets xml_i="19190" xml_f="19191" txt_i="14611" txt_f="14612">P</offsets></italic><offsets xml_i="19200" xml_f="19249" txt_i="14612" txt_f="14661"> = 0.82) and postoperatively (Mann–Whitney test: </offsets><italic><offsets xml_i="19257" xml_f="19258" txt_i="14661" txt_f="14662">P</offsets></italic><offsets xml_i="19267" xml_f="19371" txt_i="14662" txt_f="14766"> = 0.96). Likewise, hexagonality did not differ significantly between groups before (Mann–Whitney test: </offsets><italic><offsets xml_i="19379" xml_f="19380" txt_i="14766" txt_f="14767">P</offsets></italic><offsets xml_i="19389" xml_f="19428" txt_i="14767" txt_f="14806"> = 0.35) and after (Mann–Whitney test: </offsets><italic><offsets xml_i="19436" xml_f="19437" txt_i="14806" txt_f="14807">P</offsets></italic><offsets xml_i="19446" xml_f="19463" txt_i="14807" txt_f="14824"> = 0.97) surgery.</offsets></p></sec><sec><title><offsets xml_i="19485" xml_f="19510" txt_i="14826" txt_f="14851">Corneal thickness changes</offsets></title><p><offsets xml_i="19521" xml_f="19635" txt_i="14852" txt_f="14966">The preoperative CCT was 534.5 ± 29.3 μm and 536.9 ± 26.2 μm in groups I and II, respectively (Mann–Whitney test: </offsets><italic><offsets xml_i="19643" xml_f="19644" txt_i="14966" txt_f="14967">P</offsets></italic><offsets xml_i="19653" xml_f="19836" txt_i="14967" txt_f="15150"> = 0.40). The postoperative CCT was 562.6 ± 33.7 μm (increased by 28.1 ± 23.6 μm) and 560.9 ± 29.9 μm (increased by 24.0 ± 24 μm) in groups I and II, respectively (Mann–Whitney test: </offsets><italic><offsets xml_i="19844" xml_f="19845" txt_i="15150" txt_f="15151">P</offsets></italic><offsets xml_i="19854" xml_f="19951" txt_i="15151" txt_f="15248"> = 0.68). Thus, the postoperative increase in CCT was similar in both groups (Mann–Whitney test: </offsets><italic><offsets xml_i="19959" xml_f="19960" txt_i="15248" txt_f="15249">P</offsets></italic><offsets xml_i="19969" xml_f="20083" txt_i="15249" txt_f="15363"> = 0.10). The central pachymetry change with surgery was statistically significant in both groups (Wilcoxon test: </offsets><italic><offsets xml_i="20091" xml_f="20092" txt_i="15363" txt_f="15364">P</offsets></italic><offsets xml_i="20101" xml_f="20113" txt_i="15364" txt_f="15373"> &lt; 0.01).</offsets></p></sec></sec><sec sec-type="discussion"><title><offsets xml_i="20163" xml_f="20173" txt_i="15376" txt_f="15386">Discussion</offsets></title><p><offsets xml_i="20184" xml_f="20585" txt_i="15387" txt_f="15788">Technological advances in phaco have made cataract removal safer and more efficient by reducing phaco energy and duration. Torsional and transversal phaco modes are the results of these technological advances. Several studies have confirmed and reported the superiority of torsional phaco over longitudinal phaco in terms of needle time, chatter, followability, corneal edema, and corneal endothelium.</offsets><xref ref-type="bibr" rid="b1-opth-7-055"><offsets xml_i="20627" xml_f="20628" txt_i="15788" txt_f="15789">1</offsets></xref><offsets xml_i="20635" xml_f="20636" txt_i="15789" txt_f="15790">,</offsets><xref ref-type="bibr" rid="b5-opth-7-055"><offsets xml_i="20678" xml_f="20679" txt_i="15790" txt_f="15791">5</offsets></xref><offsets xml_i="20686" xml_f="20687" txt_i="15791" txt_f="15792">,</offsets><xref ref-type="bibr" rid="b7-opth-7-055"><offsets xml_i="20729" xml_f="20730" txt_i="15792" txt_f="15793">7</offsets></xref><offsets xml_i="20737" xml_f="20738" txt_i="15793" txt_f="15794">–</offsets><xref ref-type="bibr" rid="b12-opth-7-055"><offsets xml_i="20781" xml_f="20783" txt_i="15794" txt_f="15796">12</offsets></xref><offsets xml_i="20790" xml_f="20791" txt_i="15796" txt_f="15797">,</offsets><xref ref-type="bibr" rid="b19-opth-7-055"><offsets xml_i="20834" xml_f="20836" txt_i="15797" txt_f="15799">19</offsets></xref><offsets xml_i="20843" xml_f="20844" txt_i="15799" txt_f="15800">,</offsets><xref ref-type="bibr" rid="b20-opth-7-055"><offsets xml_i="20887" xml_f="20889" txt_i="15800" txt_f="15802">20</offsets></xref><offsets xml_i="20896" xml_f="20990" txt_i="15802" txt_f="15896"> However, to date, only one study has compared longitudinal, torsional, and transversal phaco.</offsets><xref ref-type="bibr" rid="b5-opth-7-055"><offsets xml_i="21032" xml_f="21033" txt_i="15896" txt_f="15897">5</offsets></xref><offsets xml_i="21040" xml_f="21150" txt_i="15897" txt_f="16007"> In that study, the clinical outcomes with three different phaco platforms were evaluated: WhiteStar Signature</offsets><sup><offsets xml_i="21155" xml_f="21156" txt_i="16007" txt_f="16008">®</offsets></sup><offsets xml_i="21162" xml_f="21197" txt_i="16008" txt_f="16043"> Ellips™ FX (transversal), Infiniti</offsets><sup><offsets xml_i="21202" xml_f="21203" txt_i="16043" txt_f="16044">®</offsets></sup><offsets xml_i="21209" xml_f="21214" txt_i="16044" txt_f="16049"> OZil</offsets><sup><offsets xml_i="21219" xml_f="21220" txt_i="16049" txt_f="16050">®</offsets></sup><offsets xml_i="21226" xml_f="21256" txt_i="16050" txt_f="16080"> IP (torsional), and Stellaris</offsets><sup><offsets xml_i="21261" xml_f="21262" txt_i="16080" txt_f="16081">®</offsets></sup><offsets xml_i="21268" xml_f="21874" txt_i="16081" txt_f="16687"> (longitudinal). Those authors found that the torsional machine had less phaco needle time, less chatter, better followability, and yielded less central corneal edema than the transversal or longitudinal machines. However, they did not compare the effect of using the platforms in terms of the corneal endothelium. The aim of the current study was to compare and evaluate the corneal morphological changes, including endothelial modifications, as an indicator of safety for cataract surgery through a 2.2 mm corneal incision. This study compared and evaluated the transversal and torsional phaco platforms.</offsets></p><p><offsets xml_i="21881" xml_f="22114" txt_i="16688" txt_f="16921">Because of different algorithms adopted by the two platforms, the current comparative analysis did not measure the effective phaco time, cumulative dissipated energy, phaco time, or balanced salt solution consumption. Georgescu et al</offsets><xref ref-type="bibr" rid="b17-opth-7-055"><offsets xml_i="22157" xml_f="22159" txt_i="16921" txt_f="16923">17</offsets></xref><offsets xml_i="22166" xml_f="22308" txt_i="16923" txt_f="17065"> demonstrated that a comparable unoccluded flow vacuum of 60 mL/min would correspond with approximately 220 mmHg and 120 mmHg for the Infiniti</offsets><sup><offsets xml_i="22313" xml_f="22314" txt_i="17065" txt_f="17066">®</offsets></sup><offsets xml_i="22320" xml_f="22344" txt_i="17066" txt_f="17090"> and WhiteStar Signature</offsets><sup><offsets xml_i="22349" xml_f="22350" txt_i="17090" txt_f="17091">®</offsets></sup><offsets xml_i="22356" xml_f="22582" txt_i="17091" txt_f="17317"> platforms, respectively. Our comparative analysis preferred the use of independent and more clinically significant parameters, such as wound stretch, corneal edema, endothelial cell loss, pleomorphism, and central pachymetry.</offsets></p><p><offsets xml_i="22589" xml_f="22999" txt_i="17318" txt_f="17728">The function of followability is to bring free nuclear fragments close to the phaco tip for continuous and smoothly progressive emulsification and aspiration. Fluidic models have shown that the longitudinal movement repels lens material from the tip, whereas the rotational motion of torsional US reduces the repulsion of the lens fragments, thus improving followability of nuclear material into the phaco tip.</offsets><xref ref-type="bibr" rid="b20-opth-7-055"><offsets xml_i="23042" xml_f="23044" txt_i="17728" txt_f="17730">20</offsets></xref><offsets xml_i="23051" xml_f="23576" txt_i="17730" txt_f="18255"> Longitudinal phaco tip movement repels lens matter with every stroke. Conversely, lateral movement reduces repulsion of the lens fragments, thus improving followability during phaco. In transversal phaco, nuclear fragments are exposed to shearing stress and the jackhammering effect caused by the transversal and longitudinal motion, respectively, but without the repulsion seen in longitudinal phaco. Furthermore, with the Ellips™ FX, the longitudinal US could not be separated from the transversal component. With the OZil</offsets><sup><offsets xml_i="23581" xml_f="23582" txt_i="18255" txt_f="18256">®</offsets></sup><offsets xml_i="23588" xml_f="23891" txt_i="18256" txt_f="18559"> IP, the longitudinal component might be switched off or set to an automatic activation when a preset threshold vacuum was reached. For this reason, a better followability was expected in the torsional group than the transversal group. However, both systems showed improved and comparable followability.</offsets></p><p><offsets xml_i="23898" xml_f="23913" txt_i="18560" txt_f="18575">Georgescu et al</offsets><xref ref-type="bibr" rid="b17-opth-7-055"><offsets xml_i="23956" xml_f="23958" txt_i="18575" txt_f="18577">17</offsets></xref><offsets xml_i="23965" xml_f="24054" txt_i="18577" txt_f="18666"> demonstrated that the postocclusion surge (POS) was significantly worse for the Infiniti</offsets><sup><offsets xml_i="24059" xml_f="24060" txt_i="18666" txt_f="18667">®</offsets></sup><offsets xml_i="24066" xml_f="24108" txt_i="18667" txt_f="18709"> platform than for the WhiteStar Signature</offsets><sup><offsets xml_i="24113" xml_f="24114" txt_i="18709" txt_f="18710">®</offsets></sup><offsets xml_i="24120" xml_f="24390" txt_i="18710" txt_f="18980"> platform. However, this could only be clinically important in extreme experimental conditions, such as using 60 mL/min of flow, a 550 mmHg vacuum, and a bottle height of 60 cm. POS is often at its worst when dealing with a broken capsule and corneal endothelial damage.</offsets><xref ref-type="bibr" rid="b17-opth-7-055"><offsets xml_i="24433" xml_f="24435" txt_i="18980" txt_f="18982">17</offsets></xref><offsets xml_i="24442" xml_f="24592" txt_i="18982" txt_f="19132"> According to the settings used in our study, we expected the POS to be negligible. Indeed, no POS was noticed during surgery in either of our groups.</offsets></p><p><offsets xml_i="24599" xml_f="25251" txt_i="19133" txt_f="19785">Regarding corneal incision size before IOL implantation, no statistically significant differences were found between the groups. The minimal wound stretch found in group I may be attributable to the compliant nature of the sleeve and the microvoid between the phaco tip and incision. Hence, the transversal movement of the phaco tip did not induce wound stress or burn. It should be noted that the new, ultrasleeve 21G tip was used with the Ellips™ FX in our study. This use was off-label, due to its commercial unavailability at the beginning of the study. As for group II, our results were consistent with previous scientific evidence. Han and Miller</offsets><xref ref-type="bibr" rid="b19-opth-7-055"><offsets xml_i="25294" xml_f="25296" txt_i="19785" txt_f="19787">19</offsets></xref><offsets xml_i="25303" xml_f="25412" txt_i="19787" txt_f="19896"> reported that torsional phaco created less heat than longitudinal phaco. In concordance with this, Jun et al</offsets><xref ref-type="bibr" rid="b10-opth-7-055"><offsets xml_i="25455" xml_f="25457" txt_i="19896" txt_f="19898">10</offsets></xref><offsets xml_i="25464" xml_f="25609" txt_i="19898" txt_f="20043"> stated that the smaller incision phaco of torsional US may decrease the risk for wound burn in eyes with denser cataracts. Furthermore, Li et al</offsets><xref ref-type="bibr" rid="b21-opth-7-055"><offsets xml_i="25652" xml_f="25654" txt_i="20043" txt_f="20045">21</offsets></xref><offsets xml_i="25661" xml_f="26291" txt_i="20045" txt_f="20675"> have recently demonstrated that, in the context of torsional phaco, a micro-coaxial, 2.2 mm incision may cause slightly less damage than the 2.8 mm standard incision. Therefore, considering the twist movement of the phaco tip in torsional US and considering that the mini-flare tip and ultra-sleeve used in group II were designed to fit 2.2 mm and 2.4 mm incisions, the minimal wound stretch found in this group seems to be a coherent finding. Finally, the enhanced followability with the torsional phaco mode reduced the additional hand-piece movements to reacquire the nuclear fragments, minimizing the stretch in the incision.</offsets><xref ref-type="bibr" rid="b20-opth-7-055"><offsets xml_i="26334" xml_f="26336" txt_i="20675" txt_f="20677">20</offsets></xref></p><p><offsets xml_i="26350" xml_f="26547" txt_i="20678" txt_f="20875">The mean endothelial cell loss in the current study was 1.7% and 2.0% in groups I and II, respectively. These values were better than those obtained in other studies using the torsional technology.</offsets><xref ref-type="bibr" rid="b8-opth-7-055"><offsets xml_i="26589" xml_f="26590" txt_i="20875" txt_f="20876">8</offsets></xref><offsets xml_i="26597" xml_f="26598" txt_i="20876" txt_f="20877">,</offsets><xref ref-type="bibr" rid="b9-opth-7-055"><offsets xml_i="26640" xml_f="26641" txt_i="20877" txt_f="20878">9</offsets></xref><offsets xml_i="26648" xml_f="26992" txt_i="20878" txt_f="21222"> This may be attributable to the use of an improved technology, the different surgical technique, the ophthalmic viscoelastic device used, and the different classification system adopted (LOCS III vs LOCS II). One study found an endothelial cell loss of 7.2% ± 4.6% using the torsional phaco technology through a 2.75 mm clear corneal incision,</offsets><xref ref-type="bibr" rid="b9-opth-7-055"><offsets xml_i="27034" xml_f="27035" txt_i="21222" txt_f="21223">9</offsets></xref><offsets xml_i="27042" xml_f="27377" txt_i="21223" txt_f="21558"> yet, in our study, no significant differences between groups were observed in endothelial cell loss, CV, and hexagonality, confirming the presence of similar postoperative levels of polymegathism and pleomorphism in both groups. Therefore, the same minimal level of endothelial damage seems to be induced with both phaco technologies.</offsets></p><p><offsets xml_i="27384" xml_f="27431" txt_i="21559" txt_f="21606">It has been postulated that a longer phaco time</offsets><xref ref-type="bibr" rid="b22-opth-7-055"><offsets xml_i="27474" xml_f="27476" txt_i="21606" txt_f="21608">22</offsets></xref><offsets xml_i="27483" xml_f="27484" txt_i="21608" txt_f="21609">,</offsets><xref ref-type="bibr" rid="b23-opth-7-055"><offsets xml_i="27527" xml_f="27529" txt_i="21609" txt_f="21611">23</offsets></xref><offsets xml_i="27536" xml_f="27556" txt_i="21611" txt_f="21631"> and higher US power</offsets><xref ref-type="bibr" rid="b22-opth-7-055"><offsets xml_i="27599" xml_f="27601" txt_i="21631" txt_f="21633">22</offsets></xref><offsets xml_i="27608" xml_f="27709" txt_i="21633" txt_f="21734"> are associated with endothelial cell loss, although some studies failed to prove these correlations.</offsets><xref ref-type="bibr" rid="b9-opth-7-055"><offsets xml_i="27751" xml_f="27752" txt_i="21734" txt_f="21735">9</offsets></xref><offsets xml_i="27759" xml_f="27760" txt_i="21735" txt_f="21736">,</offsets><xref ref-type="bibr" rid="b24-opth-7-055"><offsets xml_i="27803" xml_f="27805" txt_i="21736" txt_f="21738">24</offsets></xref><offsets xml_i="27812" xml_f="27813" txt_i="21738" txt_f="21739">,</offsets><xref ref-type="bibr" rid="b25-opth-7-055"><offsets xml_i="27856" xml_f="27858" txt_i="21739" txt_f="21741">25</offsets></xref><offsets xml_i="27865" xml_f="27880" txt_i="21741" txt_f="21756"> Reuschel et al</offsets><xref ref-type="bibr" rid="b9-opth-7-055"><offsets xml_i="27922" xml_f="27923" txt_i="21756" txt_f="21757">9</offsets></xref><offsets xml_i="27930" xml_f="28219" txt_i="21757" txt_f="22046"> found a statistically significant difference in US energy and time between the torsional and longitudinal phaco, but there was no significant correlation between these parameters and endothelial cell loss. In addition, the cell loss was not significantly different between the two groups.</offsets><xref ref-type="bibr" rid="b9-opth-7-055"><offsets xml_i="28261" xml_f="28262" txt_i="22046" txt_f="22047">9</offsets></xref><offsets xml_i="28269" xml_f="28793" txt_i="22047" txt_f="22571"> In the current study, a more significant endothelial cell loss would have been expected in the Ellips™ FX group, since the longitudinal movement component of the tip was constantly present, yet this finding was not obtained. This suggests that we have approached the critical value for safe phaco modality with the currently available torsional and transversal phaco technology, beyond which no significant improvements in endothelial cell protection can be observed. Future studies are required to confirm this hypothesis.</offsets></p><p><offsets xml_i="28800" xml_f="29072" txt_i="22572" txt_f="22844">We also found a minimal, but statistically significant increase of 28.1 and 24.0 μm in CCT in groups I and II, respectively. The difference between the groups in this minimal level of corneal edema did not reach statistical significance. However, Christakis and Braga-Mele</offsets><xref ref-type="bibr" rid="b5-opth-7-055"><offsets xml_i="29114" xml_f="29115" txt_i="22844" txt_f="22845">5</offsets></xref><offsets xml_i="29122" xml_f="29549" txt_i="22845" txt_f="23272"> found that torsional technology yielded less central corneal edema than the transversal and longitudinal technologies, corresponding to a smaller increase in the mean corneal thickness (torsional, 5%; transversal, 10%; longitudinal, 12%). One of the main factors accounting for this discrepancy with our findings may be the difference in the nuclear cataract grade, which was NC 2.0 ± 0.8 in Christakis and Braga-Mele’s study.</offsets><xref ref-type="bibr" rid="b5-opth-7-055"><offsets xml_i="29591" xml_f="29592" txt_i="23272" txt_f="23273">5</offsets></xref></p></sec><sec><title><offsets xml_i="29621" xml_f="29631" txt_i="23275" txt_f="23285">Conclusion</offsets></title><p><offsets xml_i="29642" xml_f="29673" txt_i="23286" txt_f="23317">Ellips™ FX transversal and OZil</offsets><sup><offsets xml_i="29678" xml_f="29679" txt_i="23317" txt_f="23318">®</offsets></sup><offsets xml_i="29685" xml_f="30346" txt_i="23318" txt_f="23979"> IP torsional phaco platforms are safe for performing cataract surgery, inducing minimal corneal thickness and endothelial changes. In terms of followability, the effect on the endothelium and the corneal incision, and the induced corneal thickness increase, both technologies seem to be equivalent for extraction of an NC 2–4 (LOCS III) cataract through a 2.2 mm incision. Future optical coherence tomography studies are needed to compare the effects of torsional and transversal phaco types on the corneal incision. In addition, the potential benefits and applicability of these technologies in eyes with a compromised endothelium should be further evaluated.</offsets></p></sec></body><back><fn-group><fn id="fn1-opth-7-055"><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-opth-7-055"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal></etal></person-group><article-title>Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study</article-title><source>J Cataract Refract Surg</source><year>2007</year><volume>33</volume><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">17276271</pub-id></element-citation></ref><ref id="b2-opth-7-055"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>RS</given-names></name><name><surname>Fine</surname><given-names>IH</given-names></name><name><surname>Packer</surname><given-names>M</given-names></name></person-group><article-title>New phacoemulsification technology</article-title><source></source><year>2005</year><volume>16</volume><fpage>38</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">15650578</pub-id></element-citation></ref><ref id="b3-opth-7-055"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>LG</given-names></name><name><surname>Holzer</surname><given-names>MP</given-names></name><name><surname>Solomon</surname><given-names>KD</given-names></name><name><surname>Sandoval</surname><given-names>HP</given-names></name><name><surname>Auffarth</surname><given-names>GU</given-names></name><name><surname>Apple</surname><given-names>DJ</given-names></name></person-group><article-title>Endothelial cell integrity after phacoemulsification with two different handpieces</article-title><source>J Cataract Refract Surg</source><year>2004</year><volume>30</volume><fpage>478</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">15030845</pub-id></element-citation></ref><ref id="b4-opth-7-055"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosado-Adames</surname><given-names>N</given-names></name><name><surname>Afshari</surname><given-names>NA</given-names></name></person-group><article-title>The changing fate of the corneal endothelium in cataract surgery</article-title><source>Curr Opin Ophthalmol</source><year>2012</year><volume>23</volume><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22134364</pub-id></element-citation></ref><ref id="b5-opth-7-055"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christakis</surname><given-names>PG</given-names></name><name><surname>Braga-Mele</surname><given-names>RM</given-names></name></person-group><article-title>Intraoperative performance and postoperative outcome comparison of longitudinal, torsional, and transversal phacoemulsification machines</article-title><source>J Cataract Refract Surg</source><year>2012</year><volume>38</volume><fpage>234</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">22153315</pub-id></element-citation></ref><ref id="b6-opth-7-055"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YG</given-names></name><name><surname>Chung</surname><given-names>SH</given-names></name><name><surname>Joo</surname><given-names>CK</given-names></name></person-group><article-title>Comparison of micro-coaxial with standard clear corneal incisions in torsional handpiece cataract surgery</article-title><source>Ophthalmologica</source><year>2012</year><volume>227</volume><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">21832823</pub-id></element-citation></ref><ref id="b7-opth-7-055"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakhry</surname><given-names>MA</given-names></name><name><surname>El Shazly</surname><given-names>MI</given-names></name></person-group><article-title>Torsional ultrasound mode versus combined torsional and conventional ultrasound mode phacoemulsification for eyes with hard cataract</article-title><source>Clin Ophthalmol</source><year>2011</year><volume>5</volume><fpage>973</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">21792288</pub-id></element-citation></ref><ref id="b8-opth-7-055"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Wee</surname><given-names>WR</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>MK</given-names></name></person-group><article-title>The comparison between torsional and conventional mode phacoemulsification in moderate and hard cataracts</article-title><source>Korean J Ophthalmol</source><year>2010</year><volume>24</volume><fpage>336</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">21165231</pub-id></element-citation></ref><ref id="b9-opth-7-055"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuschel</surname><given-names>A</given-names></name><name><surname>Bogatsch</surname><given-names>H</given-names></name><name><surname>Barth</surname><given-names>T</given-names></name><name><surname>Wiedemann</surname><given-names>R</given-names></name></person-group><article-title>Comparison of endothelial changes and power settings between torsional and longitudinal phacoemulsification</article-title><source>J Cataract Refract Surg</source><year>2010</year><volume>36</volume><fpage>1855</fpage><lpage>1861</lpage><pub-id pub-id-type="pmid">21029892</pub-id></element-citation></ref><ref id="b10-opth-7-055"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname><given-names>B</given-names></name><name><surname>Berdahl</surname><given-names>JP</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name></person-group><article-title>Thermal study of longitudinal and torsional ultrasound phacoemulsification: tracking the temperature of the corneal surface, incision, and handpiece</article-title><source>J Cataract Refract Surg</source><year>2010</year><volume>36</volume><fpage>832</fpage><lpage>837</lpage><pub-id pub-id-type="pmid">20457377</pub-id></element-citation></ref><ref id="b11-opth-7-055"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasavada</surname><given-names>AR</given-names></name><name><surname>Raj</surname><given-names>SM</given-names></name><name><surname>Patel</surname><given-names>U</given-names></name><name><surname>Vasavada</surname><given-names>V</given-names></name><name><surname>Vasavada</surname><given-names>V</given-names></name></person-group><article-title>Comparison of torsional and microburst longitudinal phacoemulsification: a prospective, randomized, masked clinical trial</article-title><source>Ophthalmic Surg Lasers Imaging</source><year>2010</year><volume>41</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">20128580</pub-id></element-citation></ref><ref id="b12-opth-7-055"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rekas</surname><given-names>M</given-names></name><name><surname>Montes-Mico</surname><given-names>R</given-names></name><name><surname>Krix-Jachym</surname><given-names>K</given-names></name><name><surname>Klus</surname><given-names>A</given-names></name><name><surname>Stankiewicz</surname><given-names>A</given-names></name><name><surname>Ferrer-Blasco</surname><given-names>T</given-names></name></person-group><article-title>Comparison of torsional and longitudinal modes using phacoemulsification parameters</article-title><source>J Cataract Refract Surg</source><year>2009</year><volume>35</volume><fpage>1719</fpage><lpage>1724</lpage><pub-id pub-id-type="pmid">19781466</pub-id></element-citation></ref><ref id="b13-opth-7-055"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal></etal></person-group><article-title>Torsional ultrasound modality for hard nucleus phacoemulsification cataract extraction</article-title><source>Br J Ophthalmol</source><year>2008</year><volume>92</volume><fpage>1092</fpage><lpage>1096</lpage><pub-id pub-id-type="pmid">18567650</pub-id></element-citation></ref><ref id="b14-opth-7-055"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratnarajan</surname><given-names>G</given-names></name><name><surname>Packard</surname><given-names>R</given-names></name><name><surname>Ward</surname><given-names>M</given-names></name></person-group><article-title>Combined occlusion-triggered longitudinal and torsional phacoemulsification during coaxial micro-incision cataract surgery: effect on 30-degree mini-flared tip behavior</article-title><source>J Cataract Refract Surg</source><year>2011</year><volume>37</volume><fpage>825</fpage><lpage>829</lpage><pub-id pub-id-type="pmid">21440411</pub-id></element-citation></ref><ref id="b15-opth-7-055"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tognetto</surname><given-names>D</given-names></name><name><surname>Cecchini</surname><given-names>P</given-names></name><name><surname>Leon</surname><given-names>P</given-names></name><name><surname>Di Nicola</surname><given-names>M</given-names></name><name><surname>Ravalico</surname><given-names>G</given-names></name></person-group><article-title>Stroke dynamics and frequency of three phacoemulsification machines</article-title><source>J Cataract Refract Surg</source><year>2012</year><volume>38</volume><fpage>333</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">22322168</pub-id></element-citation></ref><ref id="b16-opth-7-055"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmutz</surname><given-names>JS</given-names></name><name><surname>Olson</surname><given-names>RJ</given-names></name></person-group><article-title>Thermal comparison of Infiniti OZil and Signature Ellips phacoemulsification systems</article-title><source>Am J Ophthalmol</source><year>2010</year><volume>149</volume><fpage>762</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">20202619</pub-id></element-citation></ref><ref id="b17-opth-7-055"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgescu</surname><given-names>D</given-names></name><name><surname>Kuo</surname><given-names>AF</given-names></name><name><surname>Kinard</surname><given-names>KI</given-names></name><name><surname>Olson</surname><given-names>RJ</given-names></name></person-group><article-title>A fluidics comparison of Alcon Infiniti, Bausch and Lomb Stellaris, and Advanced Medical Optics Signature phacoemulsification machines</article-title><source>Am J Ophthalmol</source><year>2008</year><volume>145</volume><fpage>1014</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">18343350</pub-id></element-citation></ref><ref id="b18-opth-7-055"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chylack</surname><given-names>LTJ</given-names></name><name><surname>Wolfe</surname><given-names>JK</given-names></name><name><surname>Singer</surname><given-names>DM</given-names></name><etal></etal></person-group><article-title>The lens opacities classification system III</article-title><source>Arch Ophthalmol</source><year>1993</year><volume>111</volume><fpage>831</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">8512486</pub-id></element-citation></ref><ref id="b19-opth-7-055"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>YK</given-names></name><name><surname>Miller</surname><given-names>KM</given-names></name></person-group><article-title>Heat production: longitudinal versus torsional phacoemulsification</article-title><source>J Cataract Refract Surg</source><year>2009</year><volume>35</volume><fpage>1799</fpage><lpage>1805</lpage><pub-id pub-id-type="pmid">19781477</pub-id></element-citation></ref><ref id="b20-opth-7-055"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davison</surname><given-names>JA</given-names></name></person-group><article-title>Cumulative tip travel and implied followability of longitudinal and torsional phacoemulsification</article-title><source>J Cataract Refract Surg</source><year>2008</year><volume>34</volume><fpage>986</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">18499006</pub-id></element-citation></ref><ref id="b21-opth-7-055"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Joo</surname><given-names>CK</given-names></name></person-group><article-title>Early changes in corneal edema following torsional phacoemulsification using anterior segment optical coherence tomography and Scheimpflug photography</article-title><source>Jpn J Ophthalmol</source><year>2011</year><volume>55</volume><fpage>196</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">21559908</pub-id></element-citation></ref><ref id="b22-opth-7-055"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>PD</given-names></name><name><surname>Fitzpatrick</surname><given-names>P</given-names></name><name><surname>Kilmartin</surname><given-names>DJ</given-names></name><name><surname>Beatty</surname><given-names>S</given-names></name></person-group><article-title>Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident</article-title><source>J Cataract Refract Surg</source><year>2004</year><volume>30</volume><fpage>839</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">15093647</pub-id></element-citation></ref><ref id="b23-opth-7-055"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walkow</surname><given-names>T</given-names></name><name><surname>Anders</surname><given-names>N</given-names></name><name><surname>Klebe</surname><given-names>S</given-names></name></person-group><article-title>Endothelial cell loss after phacoemulsification: relation to preoperative and intraoperative parameters</article-title><source>J Cataract Refract Surg</source><year>2000</year><volume>26</volume><fpage>727</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">10831904</pub-id></element-citation></ref><ref id="b24-opth-7-055"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosrirukvongs</surname><given-names>P</given-names></name><name><surname>Slade</surname><given-names>SG</given-names></name><name><surname>Berkeley</surname><given-names>RG</given-names></name></person-group><article-title>Corneal endothelial changes after divide and conquer versus chip and flip phacoemulsification</article-title><source>J Cataract Refract Surg</source><year>1997</year><volume>23</volume><fpage>1006</fpage><lpage>1012</lpage><pub-id pub-id-type="pmid">9379369</pub-id></element-citation></ref><ref id="b25-opth-7-055"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zetterstrom</surname><given-names>C</given-names></name><name><surname>Laurell</surname><given-names>CG</given-names></name></person-group><article-title>Comparison of endothelial cell loss and phacoemulsification energy during endocapsular phacoemulsification surgery</article-title><source>J Cataract Refract Surg</source><year>1995</year><volume>21</volume><fpage>55</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">7722904</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-opth-7-055" position="float"><label>Figure 1</label><caption><p>Scatter diagram of postoperative endothelial cells in relation to preoperative values in the two groups analyzed in the current study: group I, transversal phaco with Ellips™ FX (Abbott Medical Optics, Santa Ana, CA, USA); and group II, torsional phaco with OZil<sup>®</sup> Intelligent Phaco (Bausch and Lomb, Rochester, NY, USA).</p></caption><graphic xlink:href="opth-7-055f1"></graphic></fig><table-wrap id="t1-opth-7-055" position="float"><label>Table 1</label><caption><p>Summary of the corneal endothelial changes analyzed by specular microscopy in the two groups analyzed in the current study: group I, eyes undergoing phacoemulsification using the WhiteStar Signature<sup>®</sup> platform and the Ellips™ FX (Abbott Medical Optics, Santa Ana, CA, USA) transversal continuous ultrasound mode; and group II, eyes undergoing phacoemulsification using the Infiniti<sup>®</sup> OZil<sup>®</sup> Intelligent Phaco (Bausch and Lomb, Rochester, NY, USA) torsional ultrasound mode</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="3" colspan="1">Endothelial parameters</th><th colspan="2" align="left" valign="top" rowspan="1">Mean (SD), median (range)</th><th align="left" valign="top" rowspan="3" colspan="1"><italic>P</italic>-value (Wilcoxon test)</th></tr><tr><th colspan="2" align="left" valign="top" rowspan="1">
<hr></hr></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Preoperative</th><th align="left" valign="top" rowspan="1" colspan="1">1 month postoperative</th></tr></thead><tbody><tr><td colspan="4" align="left" valign="top" rowspan="1"><bold>Group I</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ECD (cell/mm<sup>2</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">2304.1 (122.5)</td><td align="left" valign="top" rowspan="1" colspan="1">2264.1 (129.3)</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">2303.0 (1950–2588)</td><td align="left" valign="top" rowspan="1" colspan="1">2279.0 (1924–2567)</td><td align="left" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CV</td><td align="left" valign="top" rowspan="1" colspan="1">38.2 (3.5)</td><td align="left" valign="top" rowspan="1" colspan="1">38.7 (3.2)</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">38.0 (33–45)</td><td align="left" valign="top" rowspan="1" colspan="1">39.0 (31–46)</td><td align="left" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEX (%)</td><td align="left" valign="top" rowspan="1" colspan="1">39.7 (3.1)</td><td align="left" valign="top" rowspan="1" colspan="1">38.7 (3.3)</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">39.0 (33–47)</td><td align="left" valign="top" rowspan="1" colspan="1">39.0 (33–45)</td><td align="left" valign="top" rowspan="1" colspan="1"></td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1"><bold>Group II</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ECD (cell/mm<sup>2</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">2315.6 (83.1)</td><td align="left" valign="top" rowspan="1" colspan="1">2270.3 (89.9)</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">2318.0 (2067–2466)</td><td align="left" valign="top" rowspan="1" colspan="1">2270.0 (1990–2450)</td><td align="left" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CV</td><td align="left" valign="top" rowspan="1" colspan="1">38.0 (3.2)</td><td align="left" valign="top" rowspan="1" colspan="1">38.9 (2.6)</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">38.0 (33–45)</td><td align="left" valign="top" rowspan="1" colspan="1">39.0 (33–44)</td><td align="left" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEX (%)</td><td align="left" valign="top" rowspan="1" colspan="1">39.1 (3.2)</td><td align="left" valign="top" rowspan="1" colspan="1">38.6 (3.1)</td><td align="left" valign="top" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"></td><td align="left" valign="top" rowspan="1" colspan="1">39.0 (33–45)</td><td align="left" valign="top" rowspan="1" colspan="1">39.0 (32–45)</td><td align="left" valign="top" rowspan="1" colspan="1"></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-opth-7-055"><p><bold>Abbreviations:</bold> SD, standard deviation; ECD, endothelial cell density; CV, coefficient of variation; HEX, hexagonality.</p></fn></table-wrap-foot></table-wrap></floats-group></article>